Ablation Therapy for Barrett's Esophagus: New Rules for Changing Times

Area of Science:

• Gastroenterology
• Endoscopy
• Oncology

Background:

• Barrett's esophagus (BE) is a precancerous condition.
• Endoscopic techniques offer less invasive treatment options compared to surgery.
• Advancements in diagnosis and treatment aim to prevent esophageal adenocarcinoma.

Purpose of the Study:

• To review endoscopic eradication techniques for Barrett's esophagus (BE).
• To discuss controversies surrounding BE treatment.
• To highlight the efficacy and safety of emerging endoscopic therapies.

Main Methods:

• Review of current endoscopic techniques for BE eradication.
• Analysis of data from randomized trials and high-volume registries.
• Discussion of treatment guidelines for different grades of dysplasia in BE.

Main Results:

• Endoscopic ablative therapy, especially radiofrequency ablation, is recommended for T1a esophageal adenocarcinoma and high-grade dysplasia in BE.
• Endoscopic mucosal resection can complement radiofrequency ablation for nodular and flat lesions.
• Cryotherapy and APC show promise but require further study; surveillance is necessary post-ablation due to recurrence.
• Low-grade dysplasia may be managed with endo-ablative therapy or surveillance; non-dysplastic BE management remains controversial, with surveillance recommended.

Conclusions:

• Endoscopic techniques provide a safer and less invasive alternative to esophagectomy for BE treatment.
• Evidence supports the efficacy and long-term durability of endoscopic eradication therapies.
• Ongoing research aims to improve risk stratification and treatment strategies for BE.